Retinoic acid prevents phosphorylation of pRB in normal human B lymphocytes: Regulation of cyclin E, cyclin A, and p21(Cip1)

Blood

Volumn 94, Issue 4, 1999, Pages 1348-1358

  Naderi, Soheil ^a   Blomhoff, Heidi Kill ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN A; CYCLIN E; PROTEIN P21; RETINOIC ACID;

APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL CYCLE; CELL DIFFERENTIATION; CELL GROWTH; DRUG MECHANISM; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TUMOR SUPPRESSOR GENE;

EID: 0033566642     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.4.1348     Document Type: Article

References (47)

1. Blomhoff HK, Smeland EB: Role of retinoids in normal hematopoiesis and in the immune system, in Blomhoff R (ed): Vitamin A in Health and Disease, New York, NY, Marcel Decker, 1994, p 451
2. West KP: Vitamin A deficiency. Its epidemeology and relation to child mortality and morbidity, in Blomhoff R (ed): Vitamin A in Health and Disease, New York, NY, Marcel Decker, 1994, p 585
3. Blomhoff R: Introduction. Overview of vitamin A metabolism and function, in Blomhoff R (ed): Vitamin A in Health and Disease, New York, NY, Marcel Decker, 1994, p 1
4. Ross AC: Vitamin A status: Relationship to immunity and the antibody response. Proc Soc Exp Biol Med 200:301, 1992
5. Friedman A, Mediovsky A, Leitmer G, Sklan D: Decreased resistance and immune response to Esherichia coli infection in chicks with high or low intake of vitamin A. J Nutr 121:395, 1991
6. Abb J, Deinhardt T: Effects of retinoic acid on the human lymphocyte response to mitogens. Exp Cell Biol 48:169, 1980
7. Buck J, Dannecker L, Viswanathan K, Cohen SL, Chait BT, Hämmerling U: Retinol is essential for growth of activated human B cells. J Exp Med 171:1613, 1990
8. Blomhoff HK, Smeland EB, Erikstein B, Rasmusse AM, Skrede B, Skjønsberg C, Blomhoff R: Vitamin A is a key regulator for cell growth, cytokine production and differentiation in normal B cells. J Biol Chem 25:23988, 1992
9. ++ currents and cell proliferation in a B-lymphocyte cell line. J Cell Physiol 135:317, 1988
10. Fahlman C, Jacobsen SEW, Smeland EB, Lømo J, Næss CE, Funderud S, Blomhoff HK: All-trans and 9-cis retinoic acid potently inhibit growth of normal human and murine B-cell precursors. J Immunol 155:58, 1995
11. Morgan DO: Principles of CDK regulation. Nature 374:131, 1995
12. Bartek J, Bartkova J, Lukas J: The retinoblastoma protein pathway and the restriction point. Curr Opin Cell Biol 8:805, 1996
13. Weinberg RA: Tumor suppressor genes. Science 254:1138, 1991
14. Weinberg RA: E2F and cell proliferation: A world turned upside down. Cell 85:457, 1996
15. O'Connell MJ, Chua R, Hoyos B, Buck J, Chen Y, Derguini F, Hämmerling U: Retro-retinoids in regulated cell growth and death. J Exp Med 184:549, 1996
16. Hsu CA, Rishi AK, Su-Li X, Gerald TM, Dawson MI, Schiffer C, Reichert U, Shroot B, Poirer GC, Fontana JA: Retinoid induced apoptosis in leukemia cells through a retinoic acid nuclear receptor-independent pathway. Blood 89:4470, 1997
17. Lømo J, Smeland EB, Ulven S, Natarajan V, Blomhoff R, Gandhi U, Dawson MI, Blomhoff HK: RAR, not RXR, ligands inhibit cell activation and prevent apoptosis in B-lymphocytes. J Cell Physiol 175:68, 1998
18. Apfel C, Bauer F, Crettaz M, Forni L, Kamber F, Kaufmann M, LeMotte P, Pirson W, Klaus M: A retinoic acid receptor α antagonist selectively counteracts retinoic acid effects. Proc Natl Acad Sci USA 89:7129, 1992
19. Funderud S, Erikstein B, Åsheim HC, Nustad K, Stokke T, Blomhoff HK, Holte H, Smeland EB: Functional properties of CD19+ B lymphocytes positively selected from buffy coats by immunomagnetic separation. Eur J Immunol 20:201, 1990
20. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680, 1970
21. 2. Mol Cell Biol 16:762, 1996
22. Matsushime H, Quelle DE, Shurtleff SA, Shibuya M, Sherr CJ, Kato J: D-type cyclin-dependent kinase activity in mammalian cells. Mol Cell Biol 14:2066, 1994
23. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ: Isolation of biologically active ribonucleic acid from sources enriched in ribonucleases. Biochemistry 18:5294, 1979
24. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer E, Kinzler KW, Vogelstein B: WAF1, a potential mediator of p53 tumor suppression. Cell 75:817, 1993
25. Hinds PW, Mittnacht S, Dulic V, Arnold A, Reed SI, Weinberg RA: Regulation of retinoblastoma protein functions by ectopic expresion of human cyclins. Cell 70:3, 1992
26. Erikstein BK, Schwarze P, Blomhoff KH, Funderud S, Stokke T, Smeland EB: Use of size fractionation of in vitro-activated human B lymphocytes for studies of cell cycle-dependent growth regulation. Scand J Immunol 33:51, 1991
27. Blomhoff R, Green MH, Berg T, Norum KR: Transport and storage of vitamin A. Science 250:300, 1990
28. kip cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 372:570, 1994
29. Pagano M, Tam SW, Theodoras AM, Beer-Romero P, Del Sal G, Chau V, Yew PR, Draetta GF, Rolfe M: Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269:682, 1995
30. Li Y, Jenkins CW, Nichols MA, Xiong Y: Cell cycle progression and p53 regulation of the cyclin-dependent kinase inhibitor p21. Oncogene 9:2261. 1994
31. Popmpini F, Cariati R, Zancai P, De Paoli P, Rizzo S, Tedeschi RM, Pivetta b, De Vita S, Boiocchi M, Dolcetti R: Retinoids irreversibly inhibit in vitro growth of Epstein-Barr virus-immortalized B lymphocytes. Blood 88:3147, 1996
32. Stosic-Grujicic S, Edjus L: Modulation of in vitro T cell alloreactivity by synthetic retinoids. Immunopharmacol 27:87, 1994
33. Zhou Q, Stetler-Stevenson M, Steeg P: Inhibition of cyclin D expression in human breast carcinoma cells by retinoids in vitro. Oncogene 14:107, 1997
34. Burger C, Wick M, Muller R: Lineage-specific regulation of cell cycle gene expression in differentiating myeloid cells. J Cell Sci 107:2047, 1994
35. Langenfeld J, Lonardo F, Kiyokawa H, Passalaris T, Ahn MJ, Rusch V, Dmitrovsky E: Inhibited transformation of immortalised human bronchial epithelial cells by retinoic acid is linked to cyclin E-down-regulation. Oncogene 13:1983, 1996
36. Dirks PB, Patel K, Hubbard SL, Ackerley C, Hamel PA, Rutka JT: Retinoic acid and the cyclin dependent inhibitors synergistically alter proliferation and morphology of U343 astrocytoma cells. Oncogene 15:2037, 1997
37. kip: A key mediator of retinoic acid induced growth arrest in the SMS-KCNR human neuroblastoma cell line. Oncogene 16:3337, 1998
38. kip) of cyclin-dependent kinase 4 activation. Cell 79:487, 1994
39. Liu M, Iavarone A, Freedman LP: Trancriptional activation of the human p21 (WAF/CIP) gene by retinoic acid receptor. Correlation with retinoid induction of U937 cell differentiation. J Biol Chem 271:31723, 1996
40. Zhu WY, Jones CS, Kiss A, Matsukuma K, Amin S, De Luca LM: Retinoic acid inhibition of the cell cycle progression in MCF-7 human breast cancer cells. Exp Cell Res 234:293, 1997
41. cip by expression of RasN17 in epithelial cells. Oncogene 17:47, 1998
42. LaBaer J, Garrett MD, Stevenson LF, Slingerland JM, Sandhu C, Chou HS, Fattaey A, Harlow E: New functional activities for the p21 family of CDK inhibitors. Genes Dev 11:847, 1997
43. Hiyama H, Iavarone A, Reeves SA: Regulation of the cdk inhibitor p21 gene during cell cycle progression is under the control of the transcription factor E2F. Oncogene 16:1513, 1998
44. Zhang H, Hannon GJ, Beach D: p21-containg cyclin complexes exist in both active and inactive states. Genes Dev 8:1750, 1994
45. Giguère V, Ong ES, Segui P, Evans RM: Identification of a receptor for the morphogen retinoic acid. Nature 330:624, 1987
46. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schütz G, Umesano K, Mark P, Chambon P, Evans RM: The nuclear receptor superfamily: The second decade. Cell 83:835, 1995
47. Buck J, Grun F, Derguini F, Chen Y, Kimura S, Noy N, Hämmerling U: Anhydroretinol: A naturally occurring inhibitor of lymphocyte physiology. J Exp Med 178:675, 1993